Mesothelioma Treatment Centers
ALABAMA
|
Birmingham: University of Alabama Clinical research is being conducted on the use of a ribonuclease protein + doxorubicin vs. doxorubicin, in patients with unresectable malignant mesothelioma cancer. Contact: Karen Harper, RN, BSN University of Alabama at Birmingham Comprehensive Cancer Center 1824 Sixth Avenue South Birmingham, AL 35294-3300 Telephone: 205-934-5092 Email: Karen.Harper@ccc.uab.edu |
CALIFORNIA
|
Los Angeles: Tower Hematology/Oncology Study of an investigational treatment for malignant mesothelioma patients. Contact: Dee Volkerts, Study Coordinator Tower Hematology/Oncology 8635 West Third Street, Suite 665W Los Angeles, CA 90048 |
|
San Diego: Sharp Health Care Study of an investigational treatment for malignant mesothelioma patients. Contact: Cathy K. Wood, Manager, Oncology Research Program Sharp Health Care 10835 Road to the Cure San Diego, CA 92121 Telephone: 858-450-5990 ext. 221 |
COLORADO
|
Denver: University of Colorado Study of an investigational treatment for malignant mesothelioma patients. Contact: Monica Robischon, Study Coordinator University of Colorado 4200 East 9th Avenue, B-189 Denver, CO 80262 Telephone: 303-372-9108 |
FLORIDA
|
Miami: Oncology Hematology Group of South Florida Study of an investigational treatment for malignant mesothelioma patients. Contact: Cathy Maxwell, Study Coordinator Oncology Hematology Group of South Florida 8940 North Kendall Drive, Suite 300E Miami, FL 33176 Telephone: 305-594-2141 ext. 286 |
ILLNOIS
|
Chicago: University of Chicago Medical Center Study of an investigational treatment for malignant mesothelioma patients. Contact: Tamara Guterz, Study Coordinator University of Chicago Medical Center, Section of Hematology/Oncology 5841 S. Maryland Avenue, MC2115 Chicago, IL 60637-1470 Telephone: 773-834-3137 |
KENTUCKY
|
Louisville: Kentuckiana Cancer Institute Study of an investigational treatment for malignant mesothelioma patients. Contact: Roxanne Smalley Kentuckiana Cancer Institute 100 E. Liberty Street, Suite 502 Louisville, KY 40202 Telephone: 502-561-8200 |
MASSACHUSETTS
|
Worcester: Umass Memorial Cancer Center Study of an investigational treatment for malignant mesothelioma patients Contact: Carolyn Gustison, RN, OCN, Study Coordinator Umass Memorial Cancer Center Division of Hematology/Oncology 55 Lake Avenue North Worcester, MA 01655-001 Telephone: 508-856-1385 Email: judith.odonnell@banyan.ummed.edu |
NEW JERSEY
|
Somerville: Somerset Medical Center Study of an investigational treatment for malignant mesothelioma patients. Contact: Oncology Clinical Research Coordinator Somerset Medical Center 110 Rehill Avenue Somerville, NJ 08876 Telephone: 908-685-2481 Email: jcraig@somerset-healthcare.com |
NEW YORK
|
New York City: Columbia-Presbyterian Medical Center Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma. Contact: Mary Hesdorffer, RN, BSN, Clinical Research Nurse Columbia-Presbyterian Medical Center 161 Fort Washington Avenue New York, NY 10032 Telephone: 212-305-1252 |
PENNSYLVANIA
|
Philadelphia: Presbyterian Medical Center, University of PA Health System Study of an investigational treatment for malignant mesothelioma patients. Contact: Pat Drobins, Study Coordinator Presbyterian Medical Center, U. PA Health System Medical Arts Building 51 North 39th Street Philadelphia, PA 19104 Telephone: 215-349-8913 |
TENNESSEE
|
Knoxville: Thompson Cancer Survival Center Study of an investigational treatment for malignant mesothelioma patients Contact: Sue Thompson, RN, Manager, Clinical Trials Thompson Cancer Survival Center 1915 White Avenue Knoxville, TN 37916 Telephone: 865-541-1893 Email: sbales@corhlth.com |
TEXAS
|
Austin: Lone Star Oncology Study of an investigational treatment for malignant mesothelioma patients. Contact: Tracy Bell, Study Coordinator Lone Star Oncology 11044 Research Boulevard, Suite D400 Austin, TX 78759 Telephone: 512-343-2103 Email: drjjjc@aol.com |
|
Houston: S. R. Burzynski Clinic Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma Contact: Oncology Department S. R. Burzynski Clinic 9432 Old Katy, Suite 200 Houston, TX 77055 Telephone: 713-335-5697 Email: info@burzynskiclinic.com |
|
Houston: MD Anderson Cancer Center Study of an investigational treatment for malignant mesothelioma patients. Contact: Oncology Department MD Anderson Cancer Center Department of Thoracic Head & Neck Med Onc, Box 432 1515 Holcombe Boulevard Houston, TX 77030 Telephone: 713-792-7033 ext. 3141 |
VIRGINIA
|
Charlottesville: H.O.P.E. Study of an investigational treatment for malignant mesothelioma patients. Contact: Hematology Oncology Department H.O.P.E. 459 Locust Ave. Charlottesville, VA 22902 Telephone: 434-982-8410 |
|
Newport News: Virginia Oncology Associates Study of an investigational treatment for malignant mesothelioma patients. Contact: Virginia Oncology Associates 895 Middle Ground Boulevard #200 Newport News, VA 23606 Telephone: 757-873-9400 |